|
HS Code |
433363 |
| name | Buquinolate |
| IUPAC_name | ethyl 1-(butylamino)cyclopentanecarboxylate |
| CAS_number | 5486-16-2 |
| molecular_formula | C12H23NO2 |
| molar_mass | 213.32 g/mol |
| appearance | White to off-white crystalline powder |
| category | Antimalarial agent |
| mechanism_of_action | Inhibits mitochondrial electron transport |
| route_of_administration | Oral |
| synonyms | Buquinolato, Buquinolatum |
| ATC_code | P01BX05 |
| solubility | Very slightly soluble in water |
| chemical_structure | Cyclopentane ring with ethyl and butylamino substituents |
| origin | Synthetic compound |
| usage | Experimental antimalarial drug |
As an accredited Buquinolate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Buquinolate is supplied in a sealed amber glass bottle containing 25 grams, labeled with chemical name, purity, batch number, and hazard symbols. |
| Shipping | Buquinolate is shipped in tightly sealed containers to prevent moisture and contamination, complying with regulations for hazardous chemicals. Packages are clearly labeled and protected from extreme temperatures or physical damage. During transportation, safety data sheets accompany the shipment, and all handling follows international and local guidelines for chemical safety. |
| Storage | Buquinolate should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers. Protect from moisture and direct sunlight. Store at room temperature, ideally between 15-25°C (59-77°F). Ensure that it is kept out of reach of unauthorized personnel and label the container clearly for safety. |
Applications of Buquinolate in Industrial ManufacturingAs a manufacturer of Buquinolate, we supply this quinoline-based compound for several specialized applications in industrial and animal health sectors. Our industrial-grade raw material supports standardized production, process control, and real yield optimization across downstream manufacturing. The following sections detail actual industrial segments utilizing Buquinolate, outlining regulatory compliance, recommended incorporation ratios, role in process flows, and specific finished products from each field. 1. Animal Feed Additives: Poultry Coccidiostat FormulationsFeed manufacturers use Buquinolate as an ionophore coccidiostat additive within compound feed production for poultry, particularly for broiler and layer chickens. Its inclusion targets the active inhibition of Eimeria spp. during the entire feed lifecycle, supporting healthy growth rates in intensive poultry farming. Downstream feed producers must comply with veterinary additive limits and maintain strict mixing protocols to prevent residue accumulation in edible tissues. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Veterinary Pharmaceutical PreparationsVeterinary pharmaceutical manufacturers incorporate Buquinolate as an API for oral suspensions, powders, or premix drugs formulated to prevent and manage coccidiosis in farmed poultry species. Formulation challenges such as stability, bioavailability, and palatability require careful balancing during product scaling and registration. Each downstream plant must validate their finished formulation against national veterinary medicinal product guidelines before release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Antiparasitic Premixes for Industrial AquacultureCommercial aquaculture feed manufacturers use Buquinolate premixes as an antiparasitic agent against protozoan infections in farmed freshwater and marine fish. Its controlled addition aids in minimizing outbreak cycles, ensuring fish growth rates and reducing mortality within high-density rearing systems. Each production cycle relies on precise ingredient blending and strict batch conformity to aquatic animal health requirements in export markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research-Grade Reference Material for Drug Discovery and AnalysisAcademic and industrial biotechnology laboratories source Buquinolate as a high-purity reference material for analytical calibration, bioassay development, and in vitro efficacy trials. Full traceability, spectral data, and impurity profiling are mandatory for reproducible research and method validation supporting new antiparasitic drug innovation or feed additive compliance testing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Buquinolate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Long years in the chemical industry have taught us that measuring trust comes from the real performance of a product and not from glossy catalog words. Buquinolate represents exactly that journey—straightforward chemistry that solves authentic problems in animal health. Our facility has focused on producing high-purity buquinolate that delivers consistent batch-to-batch results, minimizing the risk for customers in highly regulated markets. We see firsthand how livestock health takes more than strong claims; it demands a manufacturer’s strict controls, complete transparency, and willingness to invest in process improvement. From raw material selection to filtration and drying, every step comes with accountability.
Customers share stories about endemic coccidiosis dragging down flock performance and profits. We’ve watched as generic products in the market shift season to season, making it hard to predict outcomes or plan interventions. These frustrations prompted ongoing investments in quality controls for buquinolate. Rigorous GC and HPLC methods verify assay standards above 98%, targeting impurities below defined thresholds so feed producers get the product strength they counted on. The narrow scope of buquinolate makes it a specialist tool, often paired for integrated programs with ionophores or synthetic anticoccidials. Achieving top assay is not just a goal; it’s a promise to partners who count on reliable outcomes and full traceability in their compound feed.
In the feed additive world, compromises on process often show up as erratic flow, poor suspension, or inconsistent particle size. We learned this not in the lab, but in the pellet press rooms and on the farm floor where every practical issue turns into lost time and wasted resources. Our buquinolate model comes as a fine powder, engineered for optimal mixing in both mash and pelleted feedlines. Spot checks for moisture ensure that caking and clumping aren’t a headache for end-users. If it’s raining at the premix plant, the product still flows and disperses cleanly when it’s needed most. From years of listening to purchasing managers and feed mill technicians, we know the pain points and design our product to eliminate downtime and meet heavy production schedules.
No additive performs well unless it survives storage and handling. Many competitors in a race to be first to market cut corners on stabilization. Over the last decade, we built a manufacturing environment with controlled humidity and temperature in packaging areas, which directly reduces microbial contamination and oxidative degradation. This translates into a longer shelf life, so customers can store buffer stock for peak season pressure. Our warehouse teams do not guess at conditions; continuous monitoring and real-time data maintain integrity so the final user sees the same color, texture, and dispersibility as on the day it left the plant. These are not empty promises—we consistently monitor returned sample stability at three, six, and twelve months in real-world distribution, and we adjust our workflow to improve based on evidence.
Our buquinolate product, available under our own controlled model, offers purity that meets strict national and international pharmacopeia standards. Particle sizing is managed to balance quick dispersion with low dusting, based on real complaints from decades ago about operator exposure in open mixing systems. Moisture levels are kept under tight limits for reasons anyone working with premix knows well—unexpected hydration leads straight to clumping. Microbial limits reflect daily investments in facility hygiene, backed by ongoing staff training and batch record transparency. We do not treat these thresholds as paperwork obligations, but as a reflection of what we see our customers require to protect livestock health and pass local audits.
Those in commercial poultry understand that buquinolate’s efficacy depends on precise dosing. Over-inclusion risks, compliance issues, and under-inclusion leads to coccidiosis outbreaks. Many buyers share their concern over product strength variability from less experienced suppliers, sometimes leading to uneven results in coccidiosis control. By keeping within a tight range of content per gram, we make sure diets deliver consistent protection. We answer every inquiry with a factual certificate of analysis for each lot—practice born from years of requests for transparency from vertically integrated feed groups and independent producers alike.
From a manufacturer’s standpoint, buquinolate offers reliable action against Eimeria species responsible for clinical and subclinical coccidiosis in poultry. The product’s value comes from its selective mechanism—blocking parasite development in the digestive tract—without knocking down gut flora beyond the target range. Years of field collaboration with farm managers confirmed that birds receiving diets with buquinolate tended toward improved weight gain and reduced lesion scores compared to those on diets with unproven anticoccidials. These improvements aren’t numbers drawn from ideal laboratory trials, but reflect thousands of farm-level monitoring records our team has gathered in follow-up.
Our technical support often fields questions about withdrawal periods and residue safety. By clearing set levels within defined timelines, buquinolate grants flexibility for rotation programs or emergency interventions, subject to regulatory guidance. On the farm, this freedom gives nutritionists a tool to adapt programs mid-cycle without creating compliance headaches. The real challenge is in ensuring all handlers—from integrators to contract growers—understand application standards. We take responsibility for providing detailed usage guides, technical seminars, and on-site support wherever practical, since we know actual implementation determines outcome as much as the purity of the initial molecule.
Many customers ask about buquinolate versus well-known anticoccidial chemistries on the market. From the manufacturer's view, each compound has strengths and trade-offs. Buquinolate stands out for its specificity—it does not promote antimicrobial resistance in commensal bacteria, so the long-term stewardship angle matters to both regulators and buyers who look ahead to future market access. Our discussions with industry partners in markets with heavy scrutiny, such as the EU and Japan, highlighted deep concerns over resistance profiles from years of blanket treatments with broad-spectrum coccidiostats. Buquinolate finds its place in rotation programs designed by veterinary consultants looking to reduce dependency on any single class, supporting slower emergence of resistance and cleaner withdrawal outcomes.
Other products—monensin and salinomycin among them—offer broad action but bring distinct residue checkpoints and sometimes more challenging withdrawal protocols. Buquinolate avoids this burden, allowing integration in complex schedules without extensive downtime before slaughter. Its profile means it does not disrupt feed conversion or palatability, based on farm trials and feedback from commercial partners scaling up the use in their feed lines. In specialty applications, such as organic or “no antibiotics ever” programs, some compounds fall outside approval. Buquinolate’s registration status in several core markets opens up options for feed manufacturers serving these high-value segments, providing another rotation point to meet consumer demand.
Anyone sourcing technical-grade chemicals knows that real progress starts with habits inside the production line. We train every operations staffer to treat deviations as a sign of opportunity, not blame. Some years ago, a shipment faced issues with unexpected particle stratification, traced to a minor vibration in the sieve loader. Tackling this at root—reinforcing shaker mounts and retuning the sifting cycle—took rounds of trial and field input. The result: nearly zero off-specification batches in the following seasons and that singular adjustment worked its way into our SOP for future product lines. These improvements ripple far further than our dock door. Customer feedback forms the basis for many updates we make to packaging liners, bag thickness, and labeling legibility.
We consistently bet on transparency. Each drum or bag comes with a QR code leading directly to lot-level documentation, including details on release sampling, blending operator, and final assay review. No matter where buquinolate lands—whether the end user is in a smallholder operation or a multinational feed group—they access data that allow rapid trace-back if any issue emerges downstream. Supported by fully digitized quality and recall protocols, these safeguards are the result of learning from past incidents across the industry, not purely from theory.
Producing buquinolate means drawing from a supply chain that extends across borders and seasons. Decades ago, little thought was given to the environmental impact of intermediates and solvents in manufacture. We have made it a standing policy to minimize reliance on hazardous solvents wherever formulation allows, and we treat all effluent water through in-house biological treatment, meeting local and international discharge standards. The waste product stream finds its way to authorized recycling and disposal partners, always tracked to prevent improper handling, because sustainable manufacturing isn’t just good for public relations but crucial when neighboring communities live close to the plant.
Resource stewardship includes reducing process energy needs through optimized reaction times and recycling heat from ancillary equipment. In colder climates, recovered heat feeds into warehousing, cutting heating fuel costs while keeping storage conditions stable. Local sourcing of packaging materials shortens logistics chains, reducing transportation emissions and risk of customs-related delays. Fielding questions about carbon footprint is now routine in customer audits, and we’ve chosen to publish our lifecycle assessment data to provide a straightforward account of where further improvements are in progress.
Laboratory technology has raised the bar for detection of residues, byproducts, and potential contaminants. Buyers are more informed than ever. This change brings welcome pressure for us as direct manufacturers. Over the years, feed safety became paramount—not only for regulation but for maintaining contracts with end buyers. Every complaint, from unexpected odor in a finished feed lot to delayed dissolution in liquid preparations, received hands-on attention. Technological upgrades in drying, anti-dust agent applications, and packaging ventilation were often driven by small incidents brought to us by sharp-eyed customer teams.
Trace metal contamination used to be a hidden issue, with heavy metals like lead and cadmium slipping through weak points in incoming raw material evaluation. By implementing strict ICP-MS screening of all incoming intermediates, we cut the risk to below detection in final buquinolate. No one wants to field a recall, and we see traceability as a shield against surprises. Our batch samples are archived for long-term review in an onsite repository, giving regulatory authorities access to the same samples tested by our laboratory should queries arise.
Recent years brought home the reality that chemical manufacturing, no matter the location, depends on a fragile web of inputs. Facing sudden supply chain interruptions—raw material shortages or shipping bottlenecks—required rapid shift in sourcing approaches. We established multi-source contracts for main intermediates, building direct relationships with a network of certified suppliers. This helped us maintain steady output of buquinolate without resorting to risky substitutions or variable-grade chemistry, even in tight markets.
Panicked buyers in the past have seen alternative sources market substandard or adulterated products when supply gets tight. We continue to publish batch quality reports and host open factory visits for key partners, letting customers confirm rigorous controls with their own eyes. The worst pain in supply comes from uncertainty, not cost—knock-on effects of delayed drug availability can ripple from one link in the chain to the next. Veterans in the trade recognize that predictability matters just as much as price or assay.
Direct manufacturers stand or fall based on reputation. Customers working with our buquinolate benefit from deep technical service and field support. Our team includes chemists who talk as easily with mill operators as they do with academic partners. This feedback cycle brings practical suggestions—from extending pack sizes to accommodate new automated lines, to developing granulated forms for targeted markets, each rooted in concrete user needs. Industry partners ask about innovation pipelines, and we share active investigation updates: process intensification, reduction in process waste, and options for co-formulation with complementary ingredients.
We try to tie every batch and every order back to the experiences of our partners. Stories from the field, whether from a farm manager navigating a tough coccidiosis year or a feed miller pushing to reduce operator exposure, guide where we spend on R&D and where we focus continuous training. The buquinolate available today reflects that cumulative process—wins and setbacks, resolved bottlenecks, upgrades in drying and blending, and honest conversations about what makes life easier for the people who rely on us.
As a business that sees its product handled by real people every day, the responsibility for user safety can’t take a back seat. Modern buquinolate production lines feature dust-control measures and ergonomic packaging, cutting down on exposure risk and time spent prepping batches. Operator safety protocols include clear visual cues on packaging, educational material at the point of delivery, and optional dust masks for high-throughput customers. We don’t see these steps as luxuries—they reflect the feedback we received from users who faced allergies or respiratory symptoms from lesser products laden with fines and carrier debris.
Regular dialogue with commercial safety teams led us to refine labeling, making hazard guidance more accessible in local languages and using durable ink printing to withstand tough handling conditions. Every improvement, from packaging seams to pallet stability, traces back to feedback loops with the people using the product every day. Staff in our facility undergo annual safety recertification, building a culture of watching out for each other and the end user.
Today’s chemical manufacturing environment moves faster than ever. Buyers face pressure from both regulators and their own customers, demanding traceable, predictable, and responsibly produced ingredients. We spend less time marketing and more time on the floor—testing, problem-solving, and acting on customer feedback. Our commitment with buquinolate centers on continuous improvement, rooted not in abstract ideals but in years of direct experience serving producers who count on every shipment arriving as promised.
Few products in the anticoccidial space offer as much opportunity for intelligent integration into modern animal nutrition programs as buquinolate. Its practical strengths reflect the discipline and accountability of direct manufacturing. Whether you manage a small operation or a multinational enterprise, the difference comes from trust—earned by consistent supply, quality you can measure, and a willingness to evolve alongside the needs of people who put our product to the test every day.